Latest Roskamp Institute Stories
GLEN ALLEN, Va., Oct. 7 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) has issued the following comment by Paul L.
SARASOTA, Fla., Oct. 7 /PRNewswire-USNewswire/ -- Today the Roskamp Institute said that it is pleased to announce that it will soon begin clinical trials of RCP-006, a compound found in tobacco, for the treatment of Alzheimer's disease.
SARASOTA, Fla., Sept. 27 /PRNewswire-USNewswire/ -- Scientists at the Roskamp Institute in Sarasota, Florida, have shown that mice that naturally develop Alzheimer's are able to ward off the growth of brain cancer.
GLEN ALLEN, Va., April 7 /PRNewswire-FirstCall/ -- Star Scientific (Nasdaq: CIGX) announced today that it has completed a "Research and Royalty Agreement" with the Roskamp Institute's affiliate, SRQ Bio, LLC, under which the Institute will conduct research on a compound developed by the company's Rock Creek Pharmaceutical subsidiary that medical researchers at the Institute believe may have an application in the treatment of Alzheimer's disease.
TAMPA BAY, Fla., July 20 /PRNewswire/ -- News briefs concerning economic and business growth in the Tampa Bay Region from the Tampa Bay Partnership:USF Poly Unveils Plans for Two Incubator FacilitiesUniversity of South Florida Polytechnic announced plans to open two business incubators this fall.
University of California-Los Angeles scientists say they've created a blood test that might help predict a person's risk of developing Alzheimer's disease. UCLA scientists said they discovered a way to measure the amount of amyloid beta that is being absorbed by immune cells in the blood.
Florida's First Three-Year Neuroscience Research Doctorate Program SARASOTA, Fla., June 18 /PRNewswire/ -- Sarasota's Roskamp Institute (Roskamp) today announced the first enrollment of students in its pioneering three-year Ph.D.
Research Uncovers New Link Between Inflammation & Alzheimer's Disease SARASOTA, Fla., Dec.
SARASOTA, Fla., Oct. 21 /PRNewswire/ -- A team of world-renowned scientists today announced the launch of Archer Pharmaceuticals, Inc., a new company that will use modern technologies for the identification of novel treatments for Alzheimer's disease.
MANATEE COUNTY, Fla., Aug. 12 /PRNewswire/ -- The Roskamp Institute's Associate Clinic Director and Neuropsychologist Cheryl Luis, Ph.D., ABPP-CN was recently nominated and appointed chairperson to the Department of Elder Affairs' (DOEA) Alzheimer's Disease Initiative Advisory Committee (ADIAC).